Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

cGMP PDE inhibitors reported by DuPont Merck

Oct. 25, 1996

AM-140 available for licensing

Oct. 25, 1996

Antiarrhythmic compounds described by SKB

Oct. 25, 1996

PLC Systems' Heart Laser superior to holmium and excimer lasers for TMR

Oct. 25, 1996

GV-1201/GV-1202 available for licensing

Oct. 25, 1996

Gensia turns over development of Geomatrix nifedipine product

Oct. 25, 1996

Phase IV study results reported for ramipril

Oct. 25, 1996

Benzimidazole derivatives for use in heart failure

Oct. 18, 1996

GenVec licenses human iNOS gene from University of Pittsburgh

Oct. 18, 1996

Tsumura discloses agents for atherosclerosis

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...